These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 8894667)

  • 61. Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure.
    Mentz RJ; Stevens SR; DeVore AD; Lala A; Vader JM; AbouEzzeddine OF; Khazanie P; Redfield MM; Stevenson LW; O'Connor CM; Goldsmith SR; Bart BA; Anstrom KJ; Hernandez AF; Braunwald E; Felker GM
    JACC Heart Fail; 2015 Feb; 3(2):97-107. PubMed ID: 25543972
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Five novel mutations in the SCNN1A gene causing autosomal recessive pseudohypoaldosteronism type 1.
    Welzel M; Akin L; Büscher A; Güran T; Hauffa BP; Högler W; Leonards J; Karges B; Kentrup H; Kirel B; Senses EE; Tekin N; Holterhus PM; Riepe FG
    Eur J Endocrinol; 2013 May; 168(5):707-15. PubMed ID: 23416952
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Revealing a subclinical salt-losing phenotype in heterozygous carriers of the novel S562P mutation in the alpha subunit of the epithelial sodium channel.
    Riepe FG; van Bemmelen MX; Cachat F; Plendl H; Gautschi I; Krone N; Holterhus PM; Theintz G; Schild L
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):252-8. PubMed ID: 18547339
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Mineralocorticoid receptor mutations differentially affect individual gene expression profiles in pseudohypoaldosteronism type 1.
    Fernandes-Rosa FL; Hubert EL; Fagart J; Tchitchek N; Gomes D; Jouanno E; Benecke A; Rafestin-Oblin ME; Jeunemaitre X; Antonini SR; Zennaro MC
    J Clin Endocrinol Metab; 2011 Mar; 96(3):E519-27. PubMed ID: 21159846
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Physiological and molecular aspects of mineralocorticoid receptor action in pseudohypoaldosteronism: a responsiveness test and therapy.
    Arai K; Tsigos C; Suzuki Y; Irony I; Karl M; Listwak S; Chrousos GP
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1019-23. PubMed ID: 7962269
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Novel mutations in epithelial sodium channel (ENaC) subunit genes and phenotypic expression of multisystem pseudohypoaldosteronism.
    Edelheit O; Hanukoglu I; Gizewska M; Kandemir N; Tenenbaum-Rakover Y; Yurdakök M; Zajaczek S; Hanukoglu A
    Clin Endocrinol (Oxf); 2005 May; 62(5):547-53. PubMed ID: 15853823
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Reduced Na+, K(+)-ATPase activity in patients with pseudohypoaldosteronism.
    Bistritzer T; Evans S; Cotariu D; Goldberg M; Aladjem M
    Pediatr Res; 1994 Mar; 35(3):372-5. PubMed ID: 8190530
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Phenotypic diversity and correlation with the genotypes of pseudohypoaldosteronism type 1.
    Gopal-Kothandapani JS; Doshi AB; Smith K; Christian M; Mushtaq T; Banerjee I; Padidela R; Ramakrishnan R; Owen C; Cheetham T; Dimitri P
    J Pediatr Endocrinol Metab; 2019 Sep; 32(9):959-967. PubMed ID: 31301676
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A new syndrome: hearing loss and familial salivary gland insensitivity to aldosterone in two brothers.
    Tungland OP; Savage MO; Bellman SC
    J Laryngol Otol; 1990 Dec; 104(12):956-8. PubMed ID: 2280149
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Low renin variant of hypertension: functional relations of the renin-aldosterone pressor system].
    Shkhvatsabaia IK; Ustinova SE; Uchitel' IA; Chikhladze NM; Patrusheva IF
    Kardiologiia; 1983 Apr; 23(4):5-10. PubMed ID: 6345888
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension].
    Marzecka J
    Ann Acad Med Stetin; 1996; 42():123-38. PubMed ID: 9199117
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Twenty-one additional cases of familial renal glucosuria: absence of genetic heterogeneity, high prevalence of private mutations and further evidence of volume depletion.
    Calado J; Sznajer Y; Metzger D; Rita A; Hogan MC; Kattamis A; Scharf M; Tasic V; Greil J; Brinkert F; Kemper MJ; Santer R
    Nephrol Dial Transplant; 2008 Dec; 23(12):3874-9. PubMed ID: 18622023
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Molecular pathogenesis of renal pseudohypoaldosteronism type 1.
    Riepe FG
    Expert Rev Endocrinol Metab; 2007 May; 2(3):407-419. PubMed ID: 30743803
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The renin-angiotensin-aldosterone system in the newborn lamb: response to furosemide.
    Siegel SR; Fisher DA
    Pediatr Res; 1977 Jul; 11(7):837-9. PubMed ID: 876706
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Mineralocorticoid resistance.
    Zennaro MC
    Steroids; 1996 Apr; 61(4):189-92. PubMed ID: 8732998
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Performance of the basal aldosterone to renin ratio and of the renin stimulation test by furosemide and upright posture in screening for aldosterone-producing adenoma in low renin hypertensives.
    Hirohara D; Nomura K; Okamoto T; Ujihara M; Takano K
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4292-8. PubMed ID: 11549664
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Retinal vasculopathy is reduced by dietary salt restriction: involvement of Glia, ENaCα, and the renin-angiotensin-aldosterone system.
    Deliyanti D; Armani R; Casely D; Figgett WA; Agrotis A; Wilkinson-Berka JL
    Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):2033-41. PubMed ID: 25012132
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Long term observations in a patient with pseudohypoaldosteronism.
    Hogg RJ; Marks JF; Marver D; Frolich JC
    Pediatr Nephrol; 1991 Mar; 5(2):205-10. PubMed ID: 2031836
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Mineralocorticoid receptor mutations are the principal cause of renal type 1 pseudohypoaldosteronism.
    Pujo L; Fagart J; Gary F; Papadimitriou DT; Claës A; Jeunemaître X; Zennaro MC
    Hum Mutat; 2007 Jan; 28(1):33-40. PubMed ID: 16972228
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pseudohypoaldosteronism types I and II: little more than a name in common.
    Casas-Alba D; Vila Cots J; Monfort Carretero L; Martorell Sampol L; Zennaro MC; Jeunemaitre X; Camacho Díaz JA
    J Pediatr Endocrinol Metab; 2017 May; 30(5):597-601. PubMed ID: 28593901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.